CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top winning strategies
3.2.2. Top investment pockets

3.3. MARKET DYNAMICS

3.3.1. Drivers

3.3.1.1. Growing geriatric population and increasing prevalence of chronic diseases
3.3.1.2. Introduction of advanced interventional products
3.3.1.3. Improvement of healthcare infrastructure in developing countries
3.3.1.4. Improved insurance and reimbursement

3.3.2. Restraints

3.3.2.1. Restenosis
3.3.2.2. Stringent approval process for stents

3.3.3. Opportunities

3.3.3.1. Market opportunities in developing countries

3.3.4. Impact analysis

3.4. MARKET SHARE ANALYSIS, 2016
3.5. GOVERNMENT REGULATIONS
3.6. CLINICAL TRIALS

CHAPTER 4 GLOBAL PERIPHERAL ARTERY DISEASE MARKET, BY TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. PERIPHERAL ANGIOPLASTY BALLOONS

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Old/Normal Balloons

4.2.4.1. Market size and forecast

4.2.5. Cutting and Scoring Balloons

4.2.5.1. Market size and forecast

4.2.6. Drug-Coated Balloons

4.2.6.1. Market size and forecast

4.3. PERIPHERAL STENTS

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Self-expandable

4.3.4.1. Market size and forecast

4.3.5. Balloon-expandable

4.3.5.1. Market size and forecast

4.3.6. Covered stents

4.3.6.1. Market size and forecast

4.3.7. Drug-eluting Stents

4.3.7.1. Market size and forecast

4.4. ANGIOPLASTY CATHETERS

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
4.4.4. Angiography Catheters

4.4.4.1. Market size and forecast

4.4.5. Guiding Catheters

4.4.5.1. Market size and forecast

4.5. INFERIOR VENA CAVA (IVC) FILTERS

4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast
4.5.4. Permanent Filters

4.5.4.1. Market size and forecast

4.5.5. Retrievable Filters

4.5.5.1. Market size and forecast

4.6. PLAQUE MODIFICATION DEVICES

4.6.1. Key market trends
4.6.2. Growth factors and opportunities
4.6.3. Market size and forecast
4.6.4. Thrombectomy Devices

4.6.4.1. Market size and forecast
4.6.4.2. Mechanical Thrombectomy Devices
4.6.4.3. Market size and forecast
4.6.4.4. Aspiration Thrombectomy Devices
4.6.4.5. Market size and forecast
4.6.4.6. Rheolytic Thrombectomy Devices
4.6.4.7. Market size and forecast

4.6.5. Atherectomy Devices

4.6.5.1. Market size and forecast

4.7. HEMODYNAMIC FLOW ALTERATION DEVICES

4.7.1. Key market trends
4.7.2. Growth factors and opportunities
4.7.3. Market size and forecast
4.7.4. Embolic Protection Devices

4.7.4.1. Market size and forecast

4.7.5. Chronic Total Occlusion Devices

4.7.5.1. Market size and forecast

4.8. PERIPHERAL ACCESSORIES

4.8.1. Key market trends
4.8.2. Growth factors and opportunities
4.8.3. Market size and forecast
4.8.4. Peripheral vascular Closure Devices

4.8.4.1. Market size and forecast

4.8.5. Introducer Sheaths

4.8.5.1. Market size and forecast

4.8.6. Guidewires

4.8.6.1. Market size and forecast

4.8.7. Balloon Inflation Devices

4.8.7.1. Market size and forecast

CHAPTER 5 PERIPHERAL ARTERY DISEASE MARKET, BY REGION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. NORTH AMERICA

5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast
5.2.4. U.S.
5.2.5. Canada
5.2.6. Mexico

5.3. EUROPE

5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast
5.3.4. Germany
5.3.5. France
5.3.6. UK
5.3.7. Italy
5.3.8. Spain
5.3.9. Rest of Europe

5.4. ASIA-PACFIC

5.4.1. Key market trends
5.4.2. Key growth factors and opportunities
5.4.3. Market size and forecast
5.4.4. Japan
5.4.5. China
5.4.6. India
5.4.7. Australia
5.4.8. Rest of Asia-Pacific

5.5. LAMEA

5.5.1. Key market trends
5.5.2. Key growth factors and opportunities
5.5.3. Market size and forecast
5.5.4. Brazil
5.5.5. South Africa
5.5.6. Saudi Arabia
5.5.7. Rest of LAMEA

CHAPTER 6 COMPANY PROFILES

6.1. ABBOTT LABORATORIES

6.1.1. Company overview
6.1.2. Operating business segments
6.1.3. Business performance
6.1.4. Key strategic moves and developments

6.2. BOSTON SCIENTIFIC CORPORATION

6.2.1. Company overview
6.2.2. Operating business segments
6.2.3. Business performance
6.2.4. Key strategic moves and developments

6.3. COOK

6.3.1. Company overview
6.3.2. Operating business segments
6.3.3. Business performance
6.3.4. Key strategic moves and developments

6.4. CARDINAL HEALTH, INC.

6.4.1. Company overview
6.4.2. Operating business segments
6.4.3. Business performance
6.4.4. Key strategic moves and developments

6.5. C. R. BARD, INC.

6.5.1. Company overview
6.5.2. Operating business segments
6.5.3. Business performance
6.5.4. Key strategic moves and developments

6.6. MEDTRONIC PLC

6.6.1. Company overview
6.6.2. Operating business segments
6.6.3. Business performance
6.6.4. Key strategic moves and developments

6.7. TERUMO CORPORATION

6.7.1. Company overview
6.7.2. Operating business segments
6.7.3. Business performance
6.7.4. Key strategic moves and developments

6.8. SPECTRANETICS

6.8.1. Company overview
6.8.2. Operating business segments
6.8.3. Business performance
6.8.4. Key strategic moves and developments

6.9. ANGIODYNAMICS

6.9.1. Company overview
6.9.2. Operating business segments
6.9.3. Business performance
6.9.4. Key strategic moves and developments

6.10. BIOTRONIK

6.10.1. Company overview
6.10.2. Operating business segments
6.10.3. Business performance
6.10.4. Key strategic moves and developments

6.11. B. BRAUN MELSUNGEN AG

6.11.1. Company overview
6.11.2. Operating business segments
6.11.3. Business performance
6.11.4. Key strategic moves and developments